Dr Burrinder Grewal – Director
Burrinder has over 20 years’ experience of Investment Management (IP Group plc), Corporate Strategy (originating from the London practice of Deloitte Consulting where he worked predominately for a Pharmaceutical Industry client base) and pharmaceutical development and manufacturing. Indeed, over the last decade Burrinder has advised and delivered assignments for a large number of global pharmaceutical companies and private equity institutions covering areas such as pharmaceutical portfolio management and target asset search and selection.
An Economics graduate from Cambridge University (BA, MA), Burrinder is a qualified pharmacist, holds a doctorate in transdermal drug formulation and lectures/tutors in advanced level Economics. Burrinder is also an Independent Non-Executive Director of Parkinson’s Research Ventures Limited, a subsidiary of the charity Parkinsons UK that seeks to fund and invest in the development of new treatments and cures for Parkinson’s disease.